At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

Closer home, India’s population will continue to grow briefly from its current 1.5 billion to 1.7 billion, and then drop back to 1.5 billion by 2100—leaving the population unchanged after a 75-year ...

One in five of those who registered a business in NSW last year was born in India.

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

By Rishika Sadam March 17 (Reuters) - India's Neuberg Diagnostics plans to go public in the next six months, or by the start of 2027 at the latest, a top executive told Reuters, betting on rapid ...

India is greying fast; the support system is yet to catch up.

A Namibian cheetah named Jwala has given birth to five cubs at Kuno National Park, raising India’s cheetah population to 53 ...

Paul Ehrlich, who has died aged 93, was an entomologist specialising in butterflies, though he became better known as a ...

Natco Pharma plans to make an injection for semaglutide — the active ingredient in both Ozempic and Wegovy — that will have a starting price of Rs 1,290 a month, on the first day the generics are allo ...

India's large domestic market and young population create strong long-term growth potential, says Arvind Tiku.

Not so long ago, the conventional wisdom in most liberal/left circles was that people concerned about population growth tended to be racists, nativists, ...

With 1.4 billion people and a $160 billion annual investment gap, India's energy transition from coal to renewables will ...